Japan Secures 120 Million Vaccines For Coronavirus Efforts
JAPAN GETS 120 MILLION VACCINES – Japan has struck a deal with a German Pharmaceutical and secured 120 million doses of a potential vaccine.
BioNTech, a German pharmaceutical has been developing a vaccine for the coronavirus along with US pharmaceutical giant, Pfizer. According to a report from Philstar, the Japanese government signed a contract with the companies on Friday.
However, details of how much the country paid for the vaccines were not revealed as of yet. Meanwhile, BioNTech said that the terms of the payments would be based on the delivery and the volume of the vaccines.
READ: Coronavirus Vaccine Candidates Show Promising Results
But recently, the two labs revealed an agreement and the US placed the cost of the potential coronavirus vaccines of 100 million doses around $2 billion dollars. As per the article, deliveries to Japan were scheduled for the first half of 2021.
BioNTech and Pfizer’s COVID-19 vaccine, BNT162b had advanced their trials as results revealed to be promising. Earlier, the companies announced a mass trial for the potential cure which includes 30,000 volunteers.
Once approved, the companies plan to produce up to 100 million doses by the end of the year. Furthermore, they aim to potentially manufacture over 1.3 billion doses by the end of 2021.
There are over 200 potential vaccines being developed by researchers against COVID-19. Most experts believe that the drug would be available around late December or early next year.
However, some manufacturers claim that they could provide a vaccine as early as September and October.
Thanks for reading. We aim to provide our readers with the freshest and most in-demand content. Come back next time for the latest news here on Philnews.
Like this article? READ ALSO: COVID-19 Vaccine Likely In September – Indian Firm
